A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/24 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2198316
A method of treating a mammal in an established state of septic shock, the method comprising administering a clinically effective dose of anti-TNF monoclonal antibodies to the mammal, said antibodies being administered under conditions sufficient to alleviate the state of shock and reduce the likelihood of mortality.
Méthode pour traiter un mammifère dans un état de choc septique établi, la méthode comprenant l'administration au mammifère d'une dose cliniquement efficace d'anticorps monoclonaux anti-TNF, lesdits anticorps étant administrés dans des conditions suffisantes pour atténuer l'état de choc et réduire la probabilité de mort.
Gundel Robert
Jesmok Gary
Corporation Bayer
Swabey Ogilvy Renault
LandOfFree
Treatment of septic shock with anti-tnf antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of septic shock with anti-tnf antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of septic shock with anti-tnf antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1655891